Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge
Massachusetts
02142
United States
Tel: 617-491-9700
Fax: 617-621-0431
Website: http://www.momentapharma.com/
Email: info@momentapharma.com
About Momenta Pharmaceuticals, Inc.
Momenta is a leader in the analysis, characterization, and design of complex pharmaceutical products. Our scientific foundation is a set of tools and methods that enable one to develop a deep understanding of the links between a compound’s chemical structure, its manufacturing process and its biological function. We are applying our innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.
Our success is a result of our committed and talented people. We attract scientists exceptionally skilled in integrating information from diverse technical disciplines and task them with challenging characterization, process, and biology problems. Using this approach, we have designed tools and methods to understand the structure (characterization of chemical components), structure-process (design and control of manufacturing process) and structure-activity (relationships between structure and biological and clinical activity) of complex mixture drugs. From this knowledge comes a diversified product development pipeline consisting of complex generics, biosimilars and novel drugs designed to address a variety of medical needs.
In April 2015, Momenta announced the FDA approval of once daily Glatopa™ (glatiramer acetate injection), a fully substitutable generic version of Copaxone® 20 mg/mL. Glatopa was developed under a collaboration agreement between Momenta and Sandoz and is the second complex generic developed by Momenta to receive FDA approval.
In July 2010, Momenta announced the FDA approval of our first drug, Enoxaparin Sodium Injection developed in collaboration with Sandoz.
360 articles about Momenta Pharmaceuticals, Inc.
-
Momenta Pharmaceuticals, Inc. to Present at the Biotechnology Industry Organization (BIO) Investor Forum
10/8/2007
-
Momenta Pharmaceuticals, Inc. Announces Executive Promotions
9/27/2007
-
Momenta Pharmaceuticals, Inc. to Present At the Bear Stearns 20th Annual Healthcare Conference
9/5/2007
-
Momenta Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of 2007
8/7/2007
-
Momenta Pharmaceuticals, Inc. Announces Date of Earnings Release and Conference Call for Second Quarter 2007 Financial Results
7/13/2007
-
Momenta Pharmaceuticals, Inc. to Present At the Bank of America Health Care Conference
5/23/2007
-
Momenta Pharmaceuticals, Inc. to Present At the Citigroup 2007 Healthcare Conference
5/18/2007
-
Momenta Pharmaceuticals, Inc. Announces Date for 2007 Annual Meeting of Stockholders
5/17/2007
-
Momenta Pharmaceuticals, Inc. to Present At the Acumen BioFion Rodman & Renshaw 4th Annual Global Healthcare Conference
5/14/2007
-
Momenta Pharmaceuticals, Inc. Initiates Phase I Clinical Study for M118 Subcutaneous Formulation
5/14/2007
-
Momenta Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of 2007
5/8/2007
-
Momenta Pharmaceuticals, Inc. Announces Date of Earnings Release and Conference Call for First Quarter 2007 Financial Results
4/18/2007
-
Momenta Pharmaceuticals, Inc. to Present At the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
4/5/2007
-
Momenta Pharmaceuticals, Inc. Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology
3/26/2007
-
Momenta Pharmaceuticals, Inc. to Present At the Cowen and Company 27th Annual Health Care Conference
3/8/2007
-
Momenta Pharmaceuticals, Inc. Announces Date Of Earnings Release And Conference Call For Fourth Quarter 2006 Financial Results
1/23/2007
-
Momenta Pharmaceuticals, Inc. Announces John E. Bishop, Ph.D. Promoted To Senior Vice President, Pharmaceutical Sciences
12/22/2006
-
Momenta Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of 2006
11/3/2006
-
Momenta Pharmaceuticals, Inc. To Present At The Rodman & Renshaw 8th Annual Healthcare Conference
10/31/2006
-
Momenta Pharmaceuticals, Inc. To Present At The Cowen And Company 7th Annual Global Health Care Conference
10/31/2006